Table 1 Population characteristics.

From: Comparison of nasal microbiota between preterm and full-term infants in early life

 

Preterm infants (N = 136)

Full-term infants (N = 299)

P-value

Sex, male n (%)

73 (53.7%)

154 (51.5%)

0.751

Gestational age, weeks, mean (SD)

32.4 (2.9)

39.7 (1.1)

<0.001

Postnatal age, days, mean (SD)

85.5 (22.5)

36.0 (6.64)

<0.001

Postmenstrual age at nasal swab, weeks, mean (SD)

44.6 (1.3)

44.9 (1.3)

0.041

Maternal smoking during pregnancy, yes n (%)

8 (5.9%)

11 (3.7%)

0.42

Presence of older siblings, yes n (%)

44 (32.4%)

170 (56.9%)

<0.001

Season of swab collection

  

0.258

 Winter

39 (28.7%)

67 (22.4%)

 

 Spring

30 (22.1%)

73 (24.4%)

 

 Summer

42 (30.9%)

83 (27.8%)

 

 Fall

25 (18.4%)

76 (25.4%)

 

Cesarean section, yes n (%)

104 (76.5%)

87 (29.1%)

0.001

Probiotics, yes n (%)

55 (40.4%)

1 (0.3%)

0.001

Breastfeeding at date of nasal swab, yes n (%)

78 (57.4%)

266 (89.0%)

0.001

Chorioamnionitis, yes n (%)

37 (27.2%)

1 (0.3%)

0.001

Antibiotics during pregnancy, yes n (%)

60 (44.1%)

73 (24.4%)

<0.001

Antibiotics during last 3 months before birth, yes n (%)

51 (37.5%)

35 (11.7%)

<0.001

Intrapartal antibiotic prophylaxis (IAP), yes n (%)

96 (70.6%)

80 (26.8%)

<0.001

Postnatal antibiotics for neonatal infection, yes n (%)

56 (41.2%)

2 (0.7%)

0.001

 Empiric antibiotic, when infection is suspected

43 (76.8%)

2 (100%)

 

 Neonatal infection without focus

10 (17.9%)

  

 Early- and late-onset sepsis

3 (5.7%)

  

Postnatal antibiotics for neonatal infection, days, mean (SD)

1.7 (2.29)

0.04 (0.4)

<0.001

Hospitalization, yes n (%)

115 (84.6%)

1 (0.3%)

0.001

Length of hospitalization, days, mean (SD)

33.5 (27.4)

0.08 (1.39)

<0.001

Intubation, yes n (%)

20 (14.7%)

0 (0%)

 

Study center, n (%)

   

 Bern

1 (0.7%)

130 (43.5%)

<0.001

 Basel

135 (99.3%)

169 (56.5%)

 
  1. P-values were obtained using t-test, Mann–Whitney test, and Fisher exact test, as appropriate.